This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $2,015,775
Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform
CIHR · 2025 · Principal investigator
Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform
Principal investigators: McDonald, Emily G; Carignan, Alex; Chan, Adrienne; Chen, Yan; Daley, Peter; Daneman, Nick; Kandel, Christopher; Lee, Todd C; Longtin, Yves; Perez Patrigeon, Santiago; Wuerz, Terence
Keywords: C. Difficile; Clostridioides Difficile Infection; Diarrhea; Fidaxomicin; Nosocomial Infection; Placebo Controlled; Platform Trial; Randomized Controlled Trial; Recurrence; Vancomycin
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.